Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel L Rutishauser

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Gut Microbes|May 26, 2017
Limited engraftment of donor microbiome via one-time fecal microbial transplantation in treated HIV-infected individualsIvan Vujkovic-Cvijin, Rachel L Rutishauser, Montha Pao, et al.
Journal of Virus Eradication|March 17, 2020
A collaborative, multidisciplinary approach to HIV transmission risk mitigation during analytic treatment interruptionMichael J Peluso, Lynda Dee, Danielle Campbell, et al.
Immunity|August 12, 2009
Transcriptional repressor Blimp-1 promotes CD8(+) T cell terminal differentiation and represses the acquisition of central memory T cell propertiesRachel L Rutishauser, Gislâine A Martins, Sergey Kalachikov, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 13, 2019
Some Aspects of CD8+ T-Cell Exhaustion Are Associated With Altered T-Cell Mitochondrial Features and ROS Content in HIV InfectionChristian Deo T Deguit, Michelle Hough, Rebecca Hoh, et al.
Open Forum Infectious Diseases|August 16, 2021
Discordant Virus-Specific Antibody Levels, Antibody Neutralization Capacity, and T-cell Responses Following 3 Doses of SARS-CoV-2 Vaccination in a Patient With Connective Tissue DiseaseMichael J Peluso, Sadie E Munter, Kara L Lynch, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 14, 2021
SARS-CoV-2 Vaccination in the Context of Ongoing HIV Cure-Related Research StudiesMichael J Peluso, Lynda Dee, Jeff Taylor, et al.
BMC Infectious Diseases|September 20, 2019
Rapid development of HIV elite control in a patient with acute infectionDeirdre Morley, John S Lambert, Louise E Hogan, et al.
Cell Reports|May 18, 2022
A cytotoxic-skewed immune set point predicts low neutralizing antibody levels after Zika virus infectionElizabeth E McCarthy, Pamela M Odorizzi, Emma Lutz, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 10, 2017
Disseminated Acanthamoeba infection in a heart transplant recipient treated successfully with a miltefosine-containing regimen: Case report and review of the literatureMax N Brondfield, Michael J A Reid, Rachel L Rutishauser, et al.
BMC Infectious Diseases|October 24, 2019
Correction to: Rapid development of HIV elite control in a patient with acute infectionDeirdre Morley, John S Lambert, Louise E Hogan, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Gut Microbes|May 26, 2017
Limited engraftment of donor microbiome via one-time fecal microbial transplantation in treated HIV-infected individualsIvan Vujkovic-Cvijin, Rachel L Rutishauser, Montha Pao, et al.
Journal of Virus Eradication|March 17, 2020
A collaborative, multidisciplinary approach to HIV transmission risk mitigation during analytic treatment interruptionMichael J Peluso, Lynda Dee, Danielle Campbell, et al.
Immunity|August 12, 2009
Transcriptional repressor Blimp-1 promotes CD8(+) T cell terminal differentiation and represses the acquisition of central memory T cell propertiesRachel L Rutishauser, Gislâine A Martins, Sergey Kalachikov, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 13, 2019
Some Aspects of CD8+ T-Cell Exhaustion Are Associated With Altered T-Cell Mitochondrial Features and ROS Content in HIV InfectionChristian Deo T Deguit, Michelle Hough, Rebecca Hoh, et al.
Open Forum Infectious Diseases|August 16, 2021
Discordant Virus-Specific Antibody Levels, Antibody Neutralization Capacity, and T-cell Responses Following 3 Doses of SARS-CoV-2 Vaccination in a Patient With Connective Tissue DiseaseMichael J Peluso, Sadie E Munter, Kara L Lynch, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 14, 2021
SARS-CoV-2 Vaccination in the Context of Ongoing HIV Cure-Related Research StudiesMichael J Peluso, Lynda Dee, Jeff Taylor, et al.
BMC Infectious Diseases|September 20, 2019
Rapid development of HIV elite control in a patient with acute infectionDeirdre Morley, John S Lambert, Louise E Hogan, et al.
Cell Reports|May 18, 2022
A cytotoxic-skewed immune set point predicts low neutralizing antibody levels after Zika virus infectionElizabeth E McCarthy, Pamela M Odorizzi, Emma Lutz, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 10, 2017
Disseminated Acanthamoeba infection in a heart transplant recipient treated successfully with a miltefosine-containing regimen: Case report and review of the literatureMax N Brondfield, Michael J A Reid, Rachel L Rutishauser, et al.
BMC Infectious Diseases|October 24, 2019
Correction to: Rapid development of HIV elite control in a patient with acute infectionDeirdre Morley, John S Lambert, Louise E Hogan, et al.
Pageof 5